Ablative Solutions Announces CE Mark of the Peregrine System™ Infusion Catheter 

May 13, 2015 - PRNewswire

Ablative Solutions, Inc. (ASI), a venture-backed, privately-held clinical stage company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, today announced that it has received the CE Certificate of Conformity allowing ASI to apply the CE Mark to the Peregrine SystemTM Infusion Catheter.  This will enable the Peregrine System to be used to treat hypertensive patients in Europe with the infusion of a neurolytic agent into the perivascular space surrounding the renal artery, targeting the sympathetic nerves that contribute to hypertension.  This targeted approach offers physicians a new tool to help manage patients with high blood pressure.  more